Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.
Context. - The spread of antibiotic-resistant bacteria is associated with antibiotic use.
Children receive a significant proportion of the antibiotics prescribed each year and represent an important target group for efforts aimed at reducing unnecessary antibiotic use.
- To evaluate antibiotic-prescribing practices for children younger than 18 years who had received a diagnosis of cold, upper respiratory tract infection (URI), or bronchitis in the United States.
- Representative national survey of practicing physicians participating in the National Ambulatory Medical Care Survey conducted in 1992 with a response rate of 73%. Setting. - Office-based physician practices.
- Physicians completing patient record forms for patients younger than 18 years.
Main Outcome Measures
- Principal diagnoses and antibiotic prescriptions.
- A total of 531 pediatric office visits were recorded that included a principal diagnosis of cold, URI, or bronchitis.
Antibiotics were prescribed to 44% of patients with common colds, 46% with URls, and 75% with bronchitis.
Extrapolating to the United States, 6.5 million prescriptions (12% of all prescriptions for children) were written for children diagnosed as having a URI or nasopharyngitis (common cold), and 4.7 million (9% of all prescriptions for children) were written for children diagnosed as having bronchitis. (...)
Mots-clés Pascal : Bronchite, Infection, Voie respiratoire supérieure, Antibiotique, Prescription médicale, Pratique professionnelle, Médecin, Epidémiologie, Chimiothérapie, Traitement, Enfant, Homme, Etats Unis, Amérique du Nord, Amérique, Appareil respiratoire pathologie, Bronche pathologie, Antibactérien, Antimicrobien, Personnel sanitaire
Mots-clés Pascal anglais : Bronchitis, Infection, Upper respiratory tract, Antibiotic, Medical prescription, Professional practice, Physician, Epidemiology, Chemotherapy, Treatment, Child, Human, United States, North America, America, Respiratory disease, Bronchus disease, Antibacterial agent, Antimicrobial agent, Health staff
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0203128
Code Inist : 002B02S01. Création : 11/09/1998.